Overview

Study to Investigate the Absorption, Metabolism and Excretion of [14C] AC0010 in Patients With Advanced NSCLC

Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate Pharmacokinetics parameters of a single dose [14C] AC0010 in male Patients With Advanced NSCLC.
Phase:
Phase 1
Details
Lead Sponsor:
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Hangzhou ACEA Pharmaceutical Research Co.,Ltd.
Treatments:
Abivertinib